Tadalafil Tablet, Film Coated
Product Images NDC 67296-2237

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 67296-2237). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 01)

Chemical structure of tadalafil, depicting the molecular arrangement of its atoms and bonds, including key functional groups and ring systems characteristic of this active ingredient.*

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 02)

This figure contains four line graphs showing the effect of tadalafil versus placebo on blood pressure over time. The graphs chart differences in standing systolic, standing diastolic, supine systolic, and supine diastolic blood pressure (mmHg) across time points from 0 to 96 hours.*

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 03)

Two line graphs showing the effect on systolic blood pressure over time (0 to 24 hours post-dose). The top graph measures standing systolic BP changes, comparing Tadalafil 20 mg with doxazosin 8 mg versus placebo with doxazosin 8 mg. The bottom graph measures supine systolic BP changes under the same conditions.*

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 04)

A line chart showing systolic blood pressure (BP) changes over 12 hours after administration of tadalafil or placebo, combined with doxazosin. The chart compares 20 mg tadalafil and placebo, each with 8 mg doxazosin, at 08:00 and 20:00 dosing times.*

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 05)

A line graph depicting plasma tadalafil concentration (µg/L) over time (hours) for three dosing regimens: single 20-mg dose, single 5-mg dose, and once-daily 5-mg dose following 5 consecutive days of administration. Error bars indicate variability at each time point.*

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 06)

A line graph showing change from baseline in IPSS total score over 12 weeks of treatment comparing Tadalafil 5 mg and placebo. The x-axis represents duration of treatment in weeks (0, 4, 8, 12), and the y-axis shows change in IPSS total score, with Tadalafil 5 mg showing a greater reduction than placebo at all time points.*

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 07)

A line graph depicting change from baseline in IPSS total score over a 12-week treatment period. The x-axis represents treatment duration in weeks, and the y-axis shows change from baseline. Two lines compare Tadalafil 5 mg (solid line) and placebo (dashed line), with Tadalafil showing greater reduction in IPSS scores over time. A statistical significance indicator (p<0.01) is marked at week 4.*

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 08)

A line graph illustrating the least-squares mean change from baseline over 26 weeks of therapy comparing Tadalafil/Finasteride and Placebo/Finasteride treatments. The x-axis represents weeks of therapy (0, 4, 12, 26), and the y-axis shows the LS mean change from baseline, with data points indicating that Tadalafil/Finasteride shows greater improvement than Placebo/Finasteride at measured intervals.*

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 09)

A line graph comparing the change from baseline in IPSS total score over 12 weeks of treatment between tadalafil 5 mg and placebo. The graph shows a greater decrease in IPSS score with tadalafil compared to placebo throughout the treatment period.*

FDA Label Image

Unichem Logo (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 10)

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 11)

FDA Label Image

Tadalafil Tablets Usp 2.5 mg (Carton)

Packaging label for Tadalafil Tablets, USP 2.5 mg oral film-coated tablets. The label indicates the product is for once daily use, includes dosage instructions, and storage information. Manufactured by Unichem Laboratories Ltd. and labeled for Unichem Pharmaceuticals (USA), Inc. The label shows a barcode and states there are 2 cards of 15 tablets in the package.*

FDA Label Image

Tadalafil Tablets Usp 5 mg (Carton)

Packaging label for Tadalafil Tablets USP 5 mg film-coated oral tablets, designed for once daily use. The label includes dosage instructions, storage conditions, and manufacturer details for Unichem Laboratories Ltd. and Unichem Pharmaceuticals (USA), Inc. It also features barcodes and space for overprinting lot number, expiration date, and serial number. The label dimensions are marked as 123 mm by 75 mm by 26 mm.*

FDA Label Image

Tadalafil Tablets Usp 2.5 mg (30T Container label)

Label for Tadalafil Tablets USP 2.5 mg film-coated tablets. The label includes dosage instructions, storage conditions, and a warning to keep out of reach of children. Manufactured by Unichem Laboratories Ltd. in India and for Unichem Pharmaceuticals (USA), Inc. The label mentions a package count of 30 tablets and includes a barcode and space for 2D matrix for GTIN, serial number, expiration, and lot information.*

FDA Label Image

Tadalafil Tablets Usp 5 mg (30T Container label)

Label for tadalafil tablets USP 5 mg film-coated tablets, showing a package of 30 tablets. The label includes NDC 29300-287-13 and manufacturer information for Unichem Laboratories Ltd and Unichem Pharmaceuticals (USA), Inc. It notes storage conditions, barcodes, and a 2D matrix for GTIN, serial number, expiration, and lot information.*

FDA Label Image

Tadalafil Tablets Usp 10 mg (30T Container label)

Tadalafil Tablets USP 10 mg film-coated tablets label showing a 30-count package. The label includes the NDC number 29300-288-13, manufacturer Unichem Laboratories Ltd., and states storage instructions and a barcode. It features a warning to keep out of reach of children and specifies the tablet should not be split with the entire dose taken. A 2D Matrix code area for GTIN, serial number, expiration date, and lot number is indicated on the label.*

FDA Label Image

Tadalafil Tablets Usp 20 mg (30T Container label)

Tadalafil 20 mg film-coated tablet label showing product name, strength, and dosage form. The label includes directions about tablet handling, storage instructions, and warnings to keep out of reach of children. It states a 30 tablet quantity and identifies Unichem Laboratories Ltd. as the manufacturer, with Unichem Pharmaceuticals (USA) as the distributor. The NDC 29300-289-13 is present, along with branding logos and a barcode area.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.